Ikarian Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-217,915
| Closed | -$6.98M | – | 185 |
|
|
2022
Q1 | $6.98M | Sell |
217,915
-351,114
| -62% | -$11.3M | 0.92% | 13 |
|
|
2021
Q4 | $12.4M | Sell |
569,029
-4,351
| -0.8% | -$94.6K | 1.84% | 6 |
|
|
2021
Q3 | $12.6M | Buy |
573,380
+28,378
| +5% | +$622K | 0.89% | 6 |
|
|
2021
Q2 | $10.6M | Buy |
545,002
+99,814
| +22% | +$1.95M | 0.86% | 12 |
|
|
2021
Q1 | $7.67M | Buy |
445,188
+126,298
| +40% | +$2.18M | 0.26% | 26 |
|
|
2020
Q4 | $5.11M | Buy |
318,890
+5,000
| +2% | +$80.1K | 0.23% | 36 |
|
|
2020
Q3 | $3.35M | Buy |
313,890
+304,232
| +3,150% | +$3.25M | 0.24% | 38 |
|
|
2020
Q2 | $118K | Buy |
+9,658
| New | +$118K | 0.01% | 75 |
|
|
2020
Q1 | – | Sell |
-9,660
| Closed | -$132K | – | 129 |
|
|
2019
Q4 | $132K | Buy |
+9,660
| New | +$132K | 0.02% | 43 |
|